Rhumbline Advisers Has $268.09 Million Holdings in Danaher Co. (NYSE:DHR)

Rhumbline Advisers decreased its position in Danaher Co. (NYSE:DHR - Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,167,890 shares of the conglomerate's stock after selling 11,622 shares during the period. Rhumbline Advisers owned about 0.16% of Danaher worth $268,089,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in DHR. FMR LLC raised its stake in shares of Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Danaher by 3.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock worth $1,417,342,000 after acquiring an additional 148,251 shares during the period. Fisher Asset Management LLC raised its position in Danaher by 2.6% in the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after acquiring an additional 116,299 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after acquiring an additional 535,254 shares during the period. Finally, Montrusco Bolton Investments Inc. boosted its position in shares of Danaher by 0.6% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate's stock worth $382,936,000 after purchasing an additional 9,942 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 10.90% of the stock is owned by insiders.

Danaher Trading Up 0.3 %

Shares of NYSE DHR traded up $0.70 during midday trading on Wednesday, hitting $205.23. The stock had a trading volume of 4,572,680 shares, compared to its average volume of 4,519,168. The company has a fifty day moving average price of $228.34 and a 200 day moving average price of $248.10. The company has a market capitalization of $148.24 billion, a price-to-earnings ratio of 38.87, a PEG ratio of 2.63 and a beta of 0.83. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 EPS. On average, analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher's dividend payout ratio is currently 20.45%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on DHR. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a report on Thursday, January 30th. StockNews.com downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, December 14th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price target on the stock. JPMorgan Chase & Co. dropped their price objective on Danaher from $310.00 to $300.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, TD Cowen boosted their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.